Dr. Ayad M. Al-katib MD
Hematologist-Oncologist | Hematology & Oncology
19229 Mack Ave Suite 34 Grosse Pointe MI, 48236Rating
5/5
About
Dr. Ayad Al-katib is a hematologist oncologist practicing in Grosse Pointe, MI. Dr. Al-katib specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
University of Mosul / College of Medicine 1974
Mosul University 1974
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Treatment of a de novo fludarabine resistant-CLL xenograft model with bryostatin 1 followed by fludarabine.
- Clonal preservation of human pancreatic cell line derived from primary pancreatic adenocarcinoma.
- Bax:Bcl-2 ratio modulation by bryostatin 1 and novel antitubulin agents is important for susceptibility to drug induced apoptosis in the human early pre-B acute lymphoblastic leukemia cell line, Reh.
- Modulation of cIAP-1 by novel antitubulin agents when combined with bryostatin 1 results in increased apoptosis in the human early pre-B acute lymphoblastic leukemia cell line Reh.
- Bryostatin 1 induces ubiquitination and proteasome degradation of Bcl-2 in the human acute lymphoblastic leukemia cell line, Reh.
- Phase II trial of bryostatin 1 in patients with relapsed low-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
- Effects of combretastatin A-4 prodrug against a panel of malignant human B-lymphoid cell lines.
- The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
- Evaluation of combretastatin A-4 prodrug in a non-Hodgkin's lymphoma xenograft model: preclinical efficacy.
- Phase II study of bryostatin 1 in patients with relapsed multiple myeloma.
- Mitogen-activated protein kinase is required for bryostatin 1-induced differentiation of the human acute lymphoblastic leukemia cell line Reh.
- Combretastatin-A4 prodrug induces mitotic catastrophe in chronic lymphocytic leukemia cell line independent of caspase activation and poly(ADP-ribose) polymerase cleavage.
- 2-[4-(7-chloro-2-quinoxalinyloxy)phenoxy]-propionic acid (XK469) inhibition of topoisomerase IIbeta is not sufficient for therapeutic response in human Waldenstrom's macroglobulinemia xenograft model.
- 2-[4-(7-chloro-2-quinoxalinyloxyphenoxy]-propionic acid (XK469), an inhibitor of topoisomerase (Topo) IIbeta, up-regulates Topo IIalpha and enhances Topo IIalpha-mediated cytotoxicity.
- The Wayne State University Waldenstrom's Macroglobulinemia preclinical model for Waldenstrom's macroglobulinemia.
Treatments
- Lymphoma
- Leukemia
- Extra Corporeal Shockwave Therapy
Dr. Ayad M. Al-katib MD's Practice location
Practice At 19229 Mack Ave Suite 34
19229 Mack Ave Suite 34 -Grosse Pointe, MI 48236Get Direction
Dr. Ayad M. Al-katib MD's reviews
Write ReviewPatient Experience with Dr. Al-katib
Recommended Articles
![]()
Teen with Hodgkin Lymphoma Skates with Her Hero, Mario LemieuxLillian Tarasiewicz was diagnosed with stage 3B Hodgkin lymphoma in October of 2015. She currently resides in South Carolina, but because of her father’s Pennsylvania background, she grew up with a love for hockey and for the Pittsburgh Penguins. She always felt a special connection to Mario...
![]()
Tips for Young Adult Lymphoma Survivors to Make the Most of RecoveryIt is extremely difficult to reenter the world and normal life after battling lymphoma. Recovery is much more than the body's physical battle, but how to balance emotions and relationships as well.However, there are specific tools that can assist in adapting back into a life that may seem...
![]()
The Link Between Melatonin and LymphomaThere’s always room for improvement when it comes to the experience and outcomes of cancer treatment. Fortunately, scientists are constantly researching new, better ways to do so. Although standard treatment remains mostly the same for now, the medical community is making great strides in...
![]()
AstraZeneca Gains United States Approval for Lymphoma DrugSome forms of lymphoma are rarer than others. Most people can recognize Hodgkin lymphoma, but mantle cell lymphoma will strike them as a surprise.Because it is so rare, there are not as many drugs specific to this form of cancer. One has recently been approved in the United States, by the Food and...
![]()
Teen Finds Strength to Give Back After Battling LymphomaAyden Mills is a 14-year-old middle school student residing in Vancouver, Washington. It’s easy to wonder how someone could be an inspiration at such a young age, but what Mills has gone fought through is nothing short of amazing. Mills’s story shows how it is possible to fight through even the...
![]()
Bringing Chronic Lymphocytic Leukemia Patients and Their Doctors Together via SurveyWhile patients may entirely admire and respect their doctors, sometimes they simply do not agree with the course of action they are proposing. While this may not be a big deal for a visit about a cold or something minimal, it can be life-altering for those with chronic conditions. That is why a...
Nearby Providers
![]()
Dr. Mitchell Ford Peabody D.O.12000 E 12 Mile Rd Warren MI 48093![]()
Dr. Tarik H. Hadid MD11900 E 12 MILE RD STE 308 WARREN MI 48093![]()
Dr. Zyad Kafri MD19229 Mack Ave Grosse Pointe Woods MI 48236![]()
Dr. Voravit Ratanatharathorn MD FACP4100 John R St Detroit MI 48201![]()
Dr. Nalini Janakiraman M.D.Henry Ford Health System Detroit MI 48202![]()
Dr. Mitchell Howard Folbe MD PC115 E Long Lake Rd Troy MI 48085
Nearest Hospitals
ST JOHN HOSPITAL AND MEDICAL CENTERl
22101 MOROSS RD DETROIT MI 48236BEAUMONT HOSPITAL, GROSSE POINTEl
468 CADIEUX RD GROSSE POINTE MI 48230ST JOHN MACOMB-OAKLAND HOSPITAL-MACOMB CENTERl
11800 EAST TWELVE MILE ROAD WARREN MI 48093